Clinical Trials Directory

Trials / Completed

CompletedNCT03348917

The Effect of Skin Cleansers on the Skin Surface Microbiome

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Mundipharma Manufacturing Pte Ltd. · Industry
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study determines the effects of a single application of different antiseptic skin cleansers on the composition of the skin surface microbiome using next-generation sequencing (NGS) techniques. Twelve healthy volunteers will receive all three test products in a randomized order to compare the effects of each skin cleanser.

Detailed description

Disinfectants and oral antiseptics including PVP-I are known to kill microorganisms to a variable extent, at a variable range of time points. Microorganisms may be protected from disinfectants by production of thick masses of cells and extracellular materials, or biofilms. Moreover, antiseptics should not lead to dysbiosis after use. Dysbiosis is a negative change in the microbiome of a particular skin or mucosal region. The Human Microbiome project showed, that every area has a specific microbiota in which the human host lives with an abundance of commensal, synergistic, and potentially pathogenic microorganisms. Antiseptics with efficacy gaps and resistance may induce such dysbiosis, especially after prolonged use. It is envisaged that twelve healthy volunteers will complete the study. Each healthy volunteer will apply the test product according to a developed protocol, between established wash out periods. The ability of the test product (Commercially available - Betadine® 7.5% skin cleanser (PVP-I 7.5%)) compared to the reference products (commercially available 4% chlorhexidine skin cleanser - Unity antiseptic hand wash (no alcohol) and Plain non antibacterial soap - Guardian gel hand wash (not medicated)) to reduce resident and transient microflora will be assessed. The hand wash products will also be assessed for their ability to maintain and/or restore balanced microflora.

Conditions

Interventions

TypeNameDescription
DRUG7.5% Povidone-Iodine [PVP-I]Betadine® 7.5% skin cleanser (PVP-I 7.5%)
DRUG4% chlorhexidine skin cleanserUnity antiseptic hand wash (no alcohol)
DRUGPlain non antibacterial soapGuardian gel hand wash (not medicated),

Timeline

Start date
2017-12-28
Primary completion
2018-01-26
Completion
2018-01-26
First posted
2017-11-21
Last updated
2018-02-28

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT03348917. Inclusion in this directory is not an endorsement.